![Organogenesis Holdings Inc. logo](/logos/ORGO.webp)
Organogenesis Holdings Inc.
NASDAQ:ORGO
Overview | Financials
Company Name | Organogenesis Holdings Inc. |
Symbol | ORGO |
Currency | USD |
Price | 2.47 |
Market Cap | 327,460,248 |
Dividend Yield | 0% |
52-week-range | 1.96 - 4.705 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Gary S. Gillheeney Sr. |
Website | https://organogenesis.com |
An error occurred while fetching data.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD